Observer variation in the diagnosis of superficial oesophageal adenocarcinoma

Gut

Volumn 51, Issue 5, 2002, Pages 671-676

  Ormsby, A H ^a   Petras, R E ^b   Henricks, W H ^b   Rice, T W ^b   Rybicki, L A ^b   Richter, J E ^b   Goldblum, J R ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; SUPERFICIAL CANCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 0036838582     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.5.671     Document Type: Article

References (35)

1. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
2. Pera M, Trastek VF, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy? Ann Thorac Surg 1992;54:199-203.
3. Altorki NK, Sunagawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-100.
4. Edwards MJ, Gable Dr, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;223:585-91.
5. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastronenterology 1993;105:40-50.
6. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
7. Reid BR, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
8. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-66.
9. Altman DG. Practical Statistics for Medical Research. New York: Chapman and Hall, 1991.
10. Cohen JA. A coefficient of agreement for nominal scales. Educt Psychol Assess 1960;20:37-46.
11. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia: An indication for prophylactic esohagectomy. Ann Surg 1996;224:66-71.
12. Cameron AM, Carpenter HA. Barrett's esophagus, high-grade dysplasia and early adenocarcinoma: A pathological study. Am J Gastroenterol 1997;92:586-601.
13. Skinner EB, Walther BC, Riddell RH, et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-66.
14. Lee RG. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol 1985;12:845-52.
15. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1997;87:301-12.
16. DeMeester TR, Attwood SE, Smyrk TC, et al. Surgical therapy in Barrett's esophagus. Ann Surg 1990;212:528-42.
17. Falk GW, Rice TW, Goldblum JR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999;49:120-6.
18. Menke-Pluymers MBE, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's esophagus. Gut 1992; 33:1454-8.
19. Nabeya K, Hanaoka T, Li S, et al. What is the ideal treatment for early esophageal cancer? Endoscopy 1993;25:670-1.
20. Sugimachi K, Ikebe M, Kitamura K, et al. Long-term results of esophagectomy for early esophageal carcinoma. Hepatogastroenterology 1993;40:203-6.
21. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
22. Bogomoletz WV, Molas G, Gatey B, et al. Superficial squamous cell carcinoma of the esophagus: a report of 76 cases and review of the literature. Am J Surg Pathol 1989;13:535-46.
23. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
24. Rabinovitch PS, Longton G, Blount PL, et al. Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables. Am J Gastroenterol 2001;96:3071-83.
25. Klump B, Hsieh CJ, Holzmann K, et al. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus - A longitudinal study. Z Gastroenterol 1999;37:1005-11.
26. Moskaluk CA, Heitmiller R, Zahurak M, et al. p53 and p21 (WAF1/CIP1/SDI1) gene products in Barrett's esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996;27:1211-20.
27. Younes M, Ertan A, Lechago LV, et al. p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci 1997;42:697-701.
28. Krishnadath KK, Tilanus HW, can Blankenstein M, et al. Accumulation of p53 protein in normal dysplastic, neoplastic Barrett's esophagus. J Pathol 1995;175:175-80.
29. Peters FT, Ganesh S, Kuipers EJ, et al. Epithelial cell proliferation activity of Barrett's esophagus: Methodology and correlation with traditional cancer risk markers. Dig Dis Sci 1998;43:1501-6.
30. Polkowski W, van Lanschot JJ, Ten Kate FJ, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995;4:163-71.
31. Kitahara K, Yasui W, Yokozaki H, et al. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J Exp Ther Oncol 1996;1:7-12.
32. Arber N, Lightdate C, Rotterdam H, et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. Can Epidemiol Biomarkers Prev 1996;5:457-9.
33. Coppola D, Falcone R, Livingston S, et al. Cycline D1 expression correlates with degrees of dysplasia in Barrett's esophagus. Lab Invest 1997;76:298-302.
34. Morales CP, Lee EL, Shay JW. In situ hybridization for detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 1998;83:652-9.
35. Mullick T, Tasch JE, Ormsby AH, et al. Telomerase upregulation in Barrett's esophagus precedes the development of esophageal adenocarcinoma. Am J Gastroenterol 2001;75:S25.